Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What is the Anticipated CAGR of the Drug Discovery Services Market, and What Factors Will Drive It?
The rapid expansion of the drug discovery services market has been noticeable in recent years. The market is projected to increase from $18.27 billion in 2024 to $20.52 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.3%. The substantial growth observed in the historical period can be traced back to factors such as enhanced R&D investment, a rising disease burden, governmental funding and support, the emergence of contract research organizations (CROs), a transition towards personalized medicine, and strategies geared towards drug repurposing.
The market size of drug discovery services is projected to experience robust growth in the forthcoming years, expected to reach $34.38 billion by 2029, with a compound annual growth rate (CAGR) of 13.8%. The surge in the projected period can be linked to changes in regulation policies, innovation in drug delivery mechanisms, rising interest in immunotherapy, shift towards treatment using RNA-based therapeutics, and a heightened focus on rare diseases. Key trends during the forecast period include the incorporation of cutting-edge technology, progression of biologicals and biopharmaceuticals, the uptake of high-throughput screening, advancements in virtual screening, and the emphasis on regenerative medicine.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8324&type=smp
What External and Internal Drivers Are Contributing to the Growth of theDrug Discovery Services Market?
The escalating emphasis on drug discovery studies is anticipated to boost the drug discovery services sector. The life cycle of drug development is vital for guaranteeing the secure and efficient delivery of medications. As such, clinical trials are emerging as a fundamental segment of drug development. With the growing significance of drug development and modernization in the healthcare sector, the global demand for drug discovery trials has risen. For example, as per ClinicalTrials.gov, a portal for logging clinical trials, an upturn was noted in the total number of clinical trials from 365,000 in 2021 to 452,604 reported in May 2023. Thus, the burgeoning concentration on drug discovery trials is expected to further increase the expansion of the drug discovery services market.
What Segment Types Define the Drug Discovery Services Market Structure?
The drug discovery servicesmarket covered in this report is segmented –
1) By Type: Chemistry Services; Biology Services
2) By Process: Target Selection; Target Validation; Hit-To-Lead identification; Lead Optimization; Candidate Validation
3) By Drug Type: Biologics Drug ; Small Molecule Drug
4) By End user: Pharmaceutical And Biotechnology Companies; Academic Institutes; Other End Users
Subsegments:
1) By Chemistry Services: Medicinal Chemistry; Compound Management; High-Throughput Screening; Lead Optimization
2) By Biology Services: In Vitro Studies; In Vivo Studies; Pharmacokinetics And Pharmacodynamics (PK Or PD); Biomarker Discovery
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=8324&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Drug Discovery Services Market?
North America was the largest region in the drug discovery services market in 2024. The regions covered in the drug discovery services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Long-Term Trends Are Transforming the Competitive Landscape of the Drug Discovery Services Market?
Key players in the drug discovery services market are incorporating cutting-edge technologies such as artificial intelligence (AI) and machine learning (ML) to boost the precision and effectiveness of the drug discovery process. AI and ML are interrelated sectors within the discipline of computer science. AI involves creating computer systems that can execute tasks that would normally need human intellect, while ML, a part of AI, focuses on utilizing algorithms and statistical models to empower computers to learn from data and make forecasts or decisions accordingly. For example, in February 2024, Eurofins Discovery, a France-based firm offering support services in several industries including pharmaceuticals, revealed the introduction of an innovative platform named DiscoveryAI SAFIRE (Suite of ADMET Predictions for In Silico Refinement and Evaluation). This sophisticated platform harnesses proprietary datasets, artificial intelligence (AI), and machine learning (ML) to raise the level of the drug discovery process. SAFIRE aims to speed up the creation of new pharmaceuticals by projecting the ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) attributes of molecules. This platform exploits data from Eurofins Discovery’s extensive BioPrint database, which has been carefully gathered over years of research.
View the full report here:
https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report
What Is the Definition of the Drug Discovery Services Market?
Drug discovery services refer to the procedure for identifying potential new medicines. It combines many scientific disciplines, including biology, chemistry, and pharmacology. These drug discovery services are offered in four stages: early drug discovery, pre-clinical phase, clinical phases, and regulatory approval.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8324
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model